Acceleware announces $5 Million in new funding from Alberta Innovates

Acceleware announces $5 Million in new funding from Alberta Innovates
CALGARY – Acceleware Ltd. (TSXV: AXE), a leading developer of technologies targeting low-cost and clean extraction of heavy oil and bitumen, reported it has entered into an investment agreement with Alberta Innovates, the province of Alberta’s largest research and innovation agency. Under the terms of the agreement, Alberta Innovates agrees to provide Acceleware with a contribution of up to $5... Read More

Canadian food autonomy takes a big step forward

Canadian food autonomy takes a big step forward
  HALIFAX – We learned recently that McCain Foods has upped the ante in TruLeaf Sustainable Agriculture and its wholly-owned subsidiary GoodLeaf Farms, Canada’s largest commercial vertical farming operation. McCain has invested $65 million in GoodLeaf, making it the single largest shareholder in the venture. The idea is to create a national network of sustainable vertical farms that will bring... Read More

Pent-up demand for travel expected to drive economic recovery, says Capital Group

Pent-up demand for travel expected to drive economic recovery, says Capital Group
  TORONTO – Travel and leisure sectors have been one of the hardest hit by COVID-19, with lockdown measures and various travel bans bearing witness to a 95% decline in air travel in the early months of the crisis. Even with vaccination efforts now in full swing, the industry is slow to see change as travel bans persist. According to... Read More

Field Trip Health announces closing of $95 million

Field Trip Health announces closing of $95 million
TORONTO – Field Trip Health (CSE: FTRP; FTRP.WT; OTCQX: FTRPF), a leader in the development and delivery of psychedelic therapies is making history, announcing the closing of the largest financing of a psychedelic therapy company in Canada, cementing itself as the global leader in the delivery and development of psychedelic therapies for depression and other mental health illnesses. This $95 million bought... Read More